Innovent Biologics

Innovent Biologics is a leading biopharmaceutical company dedicated to the development, manufacturing, and commercialization of high-quality, innovative medicines. Located at 168 Dongping Street, Suzhou Industrial Park, Suzhou, Jiangsu 215123, CN, Innovent is committed to addressing major diseases such as cancer and other significant therapeutic areas.

With a fully-integrated, multi-functional platform encompassing R&D, CMC (Chemistry, Manufacturing, and Controls), clinical development, and commercialization, Innovent Biologics has built a robust pipeline of valuable assets. These include several products already approved for marketing in China, along with numerous assets in various stages of clinical trials. The company's commitment to global standards is reflected in its state-of-the-art biopharmaceutical production facility, designed and operated in compliance with cGMP standards.

Innovent Biologics continues to expand its capabilities and strengthen its position in the biopharmaceutical industry. The company’s strategic collaborations with international pharmaceutical companies further enhance its ability to deliver innovative medicines to patients. We invite the manager of Innovent Biologics to create a customized and exclusive company showcase and product listing on our platform to further highlight their achievements and offerings.